Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|March 17, 2018
Intrinsic Property Forecast Index (iPFI) as a Rule of Thumb for Medicinal Chemists to Remove a Phototoxicity LiabilityJean-François Fournier, Claire Bouix-Peter, Denis Duvert, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2024
Discovery of a novel series of selective macrocyclic PKCTheta inhibitorsStefano Crosignani, Sebastien Campos, Claire Bouix-Peter, et al.
Molecular Therapy. Nucleic Acids|February 2, 2024
Multispecies-targeting siRNAs for the modulation of JAK1 in the skinQi Tang, Katherine Y Gross, Hassan H Fakih, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2018
Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acneEtienne Thoreau, Jean-Marie Arlabosse, Claire Bouix-Peter, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Impact of Minor Structural Modifications on Properties of a Series of mTOR InhibitorsGilles Ouvry, Laurence Clary, Loïc Tomas, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonistsGilles Ouvry, Claire Bouix-Peter, Fabrice Ciesielski, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Identification of novel TACE inhibitors compatible with topical applicationGilles Ouvry, Yaël Berton, Yushma Bhurruth-Alcor, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2018
Sulfoximines as potent RORγ inverse agonistsGilles Ouvry, Franck Bihl, Claire Bouix-Peter, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2018
Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphomaJean-François Fournier, Yushma Bhurruth-Alcor, Branislav Musicki, et al.
Pageof 2